Your browser doesn't support javascript.
loading
Computationally Assisted Mechanistic Investigation and Development of Pd-Catalyzed Asymmetric Suzuki-Miyaura and Negishi Cross-Coupling Reactions for Tetra-ortho-Substituted Biaryl Synthesis.
Patel, Nitinchandra Dahyabhai; Sieber, Joshua D; Tcyrulnikov, Sergei; Simmons, Bryan J; Rivalti, Daniel; Duvvuri, Krishnaja; Zhang, Yongda; Gao, Donghong A; Fandrick, Keith R; Haddad, Nizar; Lao, Kendricks So; Mangunuru, Hari Prasad Reddy; Biswas, Soumik; Qu, Bo; Grinberg, Nelu; Pennino, Scott; Lee, Heewon; Song, Jinhua J; Gupton, B Frank; Garg, Neil K; Kozlowski, Marisa C; Senanayake, Chris H.
Affiliation
  • Patel ND; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Sieber JD; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Tcyrulnikov S; Department of Chemistry, Virginia Commonwealth University, 1001 West Main St. Richmond, VA 23284-3028, USA.
  • Simmons BJ; Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.
  • Rivalti D; Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095, USA.
  • Duvvuri K; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Zhang Y; Department of Chemical and Life Science Engineering, Virginia Commonwealth University, 601 Main St./P.O. Box 843028, Richmond, VA 23284-3028, USA.
  • Gao DA; Department of Chemistry and Biochemistry, The Ohio State University, 100 West 18th Avenue, Columbus, OH 43210, USA.
  • Fandrick KR; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Haddad N; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Lao KS; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Mangunuru HPR; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Biswas S; Department of Chemistry, University of Connecticut, 55 North Eagleville Rd., Storrs, CT 06269, USA.
  • Qu B; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Grinberg N; Department of Chemical and Life Science Engineering, Virginia Commonwealth University, 601 Main St./P.O. Box 843028, Richmond, VA 23284-3028, USA.
  • Pennino S; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Lee H; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Song JJ; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Gupton BF; Material and Analytical Sciences, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Garg NK; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Kozlowski MC; Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd., Ridgefield, CT 06877, USA.
  • Senanayake CH; Department of Chemical and Life Science Engineering, Virginia Commonwealth University, 601 Main St./P.O. Box 843028, Richmond, VA 23284-3028, USA.
ACS Catal ; 8(11): 10190-10209, 2018 Nov 02.
Article in En | MEDLINE | ID: mdl-30450265
ABSTRACT
Metal-catalyzed cross-coupling reactions are extensively employed in both academia and industry for the synthesis of biaryl derivatives for applications to both medicine and material science. Application of these methods to prepare tetra-ortho-substituted biaryls leads to chiral atropisomeric products that introduces the opportunity to use catalyst-control to develop asymmetric cross-coupling procedures to access these important compounds. Asymmetric Pd-catalyzed Suzuki-Miyaura and Negishi cross-coupling reactions to form tetra-ortho-substituted biaryls were studied employing a collection of P-chiral dihydrobenzooxaphosphole (BOP) and dihydrobenzoazaphosphole (BAP) ligands. Enantioselectivities of up to 955 and 8515 er were identified for the Suzuki-Miyaura and Negishi cross-coupling reactions, respectively. Unique ligands for the Suzuki-Miyaura reaction vs the Negishi reaction were identified. A computational study on these Suzuki-Miyaura and Negishi cross-coupling reactions enabled an understanding in the differences between the enantiodiscriminating events between these two cross-coupling reactions. These results support that enantioselectivity in the Negishi reaction results from the reductive elimination step, whereas all steps in the Suzuki-Miyaura catalytic cycle contribute to the overall enantioselection with transmetalation and reductive elimination providing the most contribution to the observed selectivities.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ACS Catal Year: 2018 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ACS Catal Year: 2018 Document type: Article Affiliation country: United States
...